Stock Exchange
Genmab A/S is listed on the NASDAQ OMX Copenhagen A/S and is a member of the Nordic MidCap Index.
ID code/ISIN: DKK0010272202
Stock Symbol: GEN
Stock Information
Number of shares: 44,907,142
Nominal value per share: DKK 1
Share capital: DKK 44,907,142
Shareholders holding more than 5% of the shares:
Glaxo Group Ltd.
Hendrickus Hubertus Franciscus Stienstra (partly through Mercurius Beleggingsmaatschappij B.V. and Stimex Participatiemaatschappij B.V.)
ATP and ATP Invest
Meditor European Master Fund Ltd.
| Subsidiary Companies |
Genmab B.V. (Netherlands) |
|
Genmab, Inc. (United States) |
|
Genmab MN, Inc. (United States) |
| Auditors |
PricewaterhouseCoopers |
| Principal Law Firms |
Shearman & Sterling LLP |
| |
Kromann Reumert |
| Key Dates |
|
| Founded |
1999 |
| First capitalization |
February 25, 1999 |
| IPO |
October 18, 2000 |
| Private Placement |
July 1, 2004 |
| Private Placement |
January 27, 2006 |
| Most recent Annual Report |
March 15, 2011 |
| Most recent Annual General Meeting |
April 6, 2011 |
| Financial Calendar year-end |
December 31, 2011 |
Election results of the Annual General Meeting 2011